Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Malays Orthop J ; 15(2): 70-76, 2021 Jul.
Article in English | MEDLINE | ID: mdl-34429825

ABSTRACT

INTRODUCTION: A dilemma arises when a bone graft or fracture fragment is accidentally dropped on the operation theatre floor and becomes contaminated. This study aimed to determine the efficacy of simple and readily available antiseptic solutions in disinfecting contaminated bones. MATERIAL AND METHODS: This experimental study involved 225 bone specimens prepared from discarded bone fragments during a series of 45 knee and hip arthroplasty surgeries. The bone fragments were cut into five identical cubes and were randomly assigned to either control (positive or negative), or experimental groups (0.5% chlorhexidine, 10% povidone-iodine or 70% alcohol). The control negative was to determine pre-contamination culture. All bone specimens, except the control negative group were uniformly contaminated by dropping on the operation theatre floor. Subsequently, the dropped bone specimens except for the control positive group, were disinfected by immersing in a respective antiseptic solution for 10 minutes, before transported to the microbiology laboratory for incubation. RESULTS: The incidence of a positive culture from a dropped bone fragment was 86.5%. From the 37 specimens sent for each group, the incidence of positive culture was 5.4% (2 specimens) after being disinfected using chlorhexidine, 67.6% (25 specimens) using povidone-iodine and 81.1% (30 specimens) using alcohol. Simple logistic regression analysis demonstrated that chlorhexidine was significantly effective in disinfecting contaminated bones (p-value <0.001, odd ratio 0.009). Povidone-iodine and alcohol were not statistically significant (p-value 0.059 and 0.53, respectively). Organisms identified were Bacillus species and coagulase negative Staphylococcus. No gram-negative bacteria were isolated. CONCLUSION: A total of 0.5% chlorhexidine is effective and superior in disinfecting contaminated bones.

2.
Int J Oral Maxillofac Surg ; 42(7): 857-62, 2013 Jul.
Article in English | MEDLINE | ID: mdl-23497981

ABSTRACT

The purpose of this study was to evaluate the intranasal use of 1.5 µg/kg atomized dexmedetomidine for sedation in patients undergoing mandibular third molar removal. Eighteen patients underwent third molar removal in two surgical sessions. Patients were randomly assigned to receive intranasal water (placebo group) or 1.5 µg/kg atomized dexmedetomidine (group D) at the first session. The alternate regimen was used during the second session. Local anaesthesia was injected 30 min after placebo/sedative administration. Pain from local anaesthesia infiltration was rated on a scale from zero (no pain) to 10 (worst pain imaginable). Sedation status was measured every 10 min by a blinded observer with a modified Observer's Assessment of Alertness/Sedation (OAA/S) scale and the bispectral index (BIS). Adverse reactions and analgesic consumption were recorded. Sedation values in group D were significantly different from placebo at 20-30 min, peaked at 40-50 min, and returned to placebo levels at 70-80 min after intranasal drug administration. Group D displayed decreased heart rate and systolic blood pressure, but the decreases did not exceed 20% of the baseline values. Intranasal administration of 1.5 µg/kg atomized dexmedetomidine is effective, convenient, and safe as a sedative for patients undergoing third molar extraction.


Subject(s)
Administration, Intranasal/methods , Anesthesia, Dental/methods , Dexmedetomidine/administration & dosage , Hypnotics and Sedatives/administration & dosage , Molar, Third/surgery , Tooth Extraction , Adult , Anesthesia, Local/methods , Anesthetics, Intravenous/administration & dosage , Dexmedetomidine/adverse effects , Female , Humans , Hypnotics and Sedatives/adverse effects , Male , Mandible/surgery , Pain Measurement , Tooth, Impacted/surgery
3.
Int J Oral Maxillofac Surg ; 42(8): 988-93, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23490474

ABSTRACT

The aim of this study was to compare fentanyl-based versus remifentanil-based anesthesia with regards to the intraoperative hemodynamic stress response and recovery profiles in patients undergoing Le Fort I osteotomy. Seventeen patients were randomly divided into two groups: patients in the F-group received 2 µg/kg fentanyl intravenously followed by an infusion of 0.03-0.06 µg/kg/min, while patients in the R-group received a 0.5 µg/kg bolus of remifentanil followed by an infusion of 0.0625-0.250 µg/kg/min. Mean arterial pressure and heart rate were recorded at the following points: before anesthetic induction, at endotracheal intubation, 5 min after intubation, at incision, just before the osteotomy, during the osteotomy, during the maxillary fracturing, at suturing, at extubation, 5 min after extubation, and then 15 and 30 min postoperatively. Heart rate and mean arterial pressure were significantly lower in the R-group in comparison to the F-group from t1 to t9 (P<0.05). All measured recovery times were significantly shorter in the R-group (P<0.05). The incidence of postoperative side effects was comparable between groups. Remifentanil-based anesthesia is an appropriate alternative to fentanyl during Le Fort I orthognathic surgery; it promotes hemodynamic stability, blunts the stress response to noxious stimuli, and provides a better recovery profile.


Subject(s)
Anesthesia Recovery Period , Anesthetics, Intravenous/administration & dosage , Arterial Pressure/drug effects , Heart Rate/drug effects , Orthognathic Surgical Procedures/methods , Osteotomy, Le Fort/methods , Piperidines/administration & dosage , Adolescent , Adult , Anesthetics, Inhalation/administration & dosage , Antihypertensive Agents/therapeutic use , Blood Loss, Surgical , Female , Fentanyl/administration & dosage , Follow-Up Studies , Humans , Intubation, Intratracheal , Labetalol/therapeutic use , Male , Maxilla/surgery , Methyl Ethers/administration & dosage , Monitoring, Intraoperative , Pain, Postoperative/etiology , Postoperative Nausea and Vomiting/etiology , Prospective Studies , Remifentanil , Sevoflurane , Single-Blind Method , Wound Closure Techniques , Young Adult
4.
Aust Dent J ; 56(3): 296-301, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21884146

ABSTRACT

BACKGROUND: The aim of this study was to evaluate the use of inhaled methoxyflurane (Penthrox) in the reduction of dental anxiety in patients undergoing mandibular third molar removal in a specialist surgical suite and compare it to the conventional nitrous oxide sedation. METHODS: A prospective randomized, non-blinded crossover design study of 20 patients receiving two types of sedation for their third molar extraction who participated in 40 treatment sessions. At first appointment, a patient was randomly assigned to receive either nitrous oxide sedation or intermittent Penthrox inhaler sedation, with the alternate regimen administered during the second appointment. Peri-procedural vital signs (heart rate and blood pressure) were recorded and any deviations from 20% from the baseline values, as well as any drop in oxygen saturation below 92% were documented. The Ramsay Sedation Scale (RSS) score was recorded every five minutes. Patient cooperation during the procedure, patients' general opinion about the sedation technique, surgeon satisfaction and the occurrence of side effects were all recorded. After the second procedure, the patient was also asked if he or she had any preference of one sedation technique over the other. RESULTS: Levels of sedation were comparable in nitrous oxide and Penthrox sedation sessions. However, at 15 minutes of sedation it was significantly lighter (p < 0.05) in Penthrox. No patient in both regimens reached a RSS deeper than a score of 4. Parameters measured for assessment of sedation (patient cooperation, surgeon satisfaction and patient general opinion about sedation technique) were all similarly comparable for both nitrous oxide and Penthrox. In both sedation sessions, the odour of the inhalational agent was accepted by the patients; half of the patients (10 patients) who received methoxyflurane thought its odour was pleasant. Patients preferred methoxyflurane (Penthrox) inhalation over nitrous oxide sedation (Fisher's Exact test, p < 0.05). Adverse events were minimal. No patient was either deeply sedated or agitated. Blood pressure was within ± 20% from the baseline values. No patient had oxygen saturation less than 92%. Dizziness was the most frequently encountered side effect in both regimens (four patients each). Two patients had bradycardia (HR < 60 beats/minute) when nitrous oxide was used in comparison to one patient with Penthrox sedation. Paraesthesia of fingers and heaviness of the chest was encountered only with nitrous oxide sedation (four patients). Mild self-limited shivering occurred in one patient with Penthrox sedation. CONCLUSIONS: The Penthrox Inhaler can produce a comparable sedation to that of nitrous oxide for the surgical extraction of third molars under local anaesthesia.


Subject(s)
Anesthetics, Inhalation/administration & dosage , Conscious Sedation/methods , Methoxyflurane/administration & dosage , Molar, Third/surgery , Nitrous Oxide/administration & dosage , Tooth Extraction , Adolescent , Adult , Anesthesia, Dental/methods , Anesthetics, Inhalation/adverse effects , Blood Pressure/physiology , Bradycardia/chemically induced , Cooperative Behavior , Cross-Over Studies , Dental Anxiety/prevention & control , Dizziness/chemically induced , Female , Fingers , Heart Rate/physiology , Humans , Male , Methoxyflurane/adverse effects , Nausea/chemically induced , Nitrous Oxide/adverse effects , Oxygen/blood , Paresthesia/chemically induced , Patient Satisfaction , Prospective Studies , Thorax/drug effects , Treatment Outcome , Young Adult
5.
J Pediatr Hematol Oncol ; 23(4): 244-6, 2001 May.
Article in English | MEDLINE | ID: mdl-11846304

ABSTRACT

We report a newborn infant girl, born to consanguineous parents, with recurrent intracranial hemorrhage secondary to congenital factor V deficiency with factor V inhibitor. Repeated transfusions of fresh-frozen plasma (FFP) and platelet concentrates, administrations of immunosuppressive therapy (prednisolone and cyclophosphamide), and intravenous immunoglobulin failed to normalize the coagulation profiles. Exchange transfusion followed-up by administrations of activated prothrombin complex and transfusions of FFP and platelet concentrates caused a temporary normalization of coagulation profile, enabling an insertion of ventriculoperitoneal (VP) shunt for progressive hydrocephalus. The treatment was complicated by thrombosis of left brachial artery and ischemia of left middle finger. The child finally died from another episode of intracranial hemorrhage 10 days after insertion of the VP shunt.


Subject(s)
Cerebral Hemorrhage/etiology , Factor V Deficiency/complications , Factor V/immunology , Isoantibodies/biosynthesis , Brachial Artery , Combined Modality Therapy , Consanguinity , Cyclophosphamide/therapeutic use , Exchange Transfusion, Whole Blood , Factor V Deficiency/immunology , Factor V Deficiency/therapy , Fatal Outcome , Female , Humans , Hydrocephalus/etiology , Hydrocephalus/surgery , Immunization , Immunoglobulins, Intravenous/therapeutic use , Immunosuppressive Agents/therapeutic use , Infant, Newborn , Isoantibodies/immunology , Plasma , Platelet Transfusion , Prednisolone/therapeutic use , Recurrence , Thrombosis/etiology , Ventriculoperitoneal Shunt
7.
Int J Infect Dis ; 4(1): 21-5, 2000.
Article in English | MEDLINE | ID: mdl-10689210

ABSTRACT

OBJECTIVES: To evaluate prevalence of ceftazidime-resistant Klebsiella pneumoniae (CRKP) in the pediatric oncology unit of University Hospital, Kuala, Lumpur, and to identify differences between febrile neutropenic pediatric patients with CRKP and ceftazidime-sensitive K. pneumoniae (CSKP) bacteremia. MATERIALS AND METHODS: Febrile neutropenic patients treated between January 1996 and December 1997 at the pediatric oncology unit of University Hospital, Kuala Lumpur, were prospectively studied. Empirical antibiotic therapy consisted of ceftazidime and amikacin. Those who developed K. pneumoniae bacteremia were identified, and clinical features analyzed. Ceftazidime-resistance was documented via disk-diffusion testing. Production of extended-spectrum beta-lactamase (ESBL) was inferred on the basis of synergy between ceftazidime and amoxicillin-clavulanic acid. The different features between the two groups and variables associated with the development of CRKP bacteremia were analyzed using chi-square and t-tests and calculation of odds ratios. A multivariate analysis was used to identify independent factors for CRKP development. RESULTS: Ceftazidime-resistance was seen in 51.6% of all K. pneumoniae isolates, and all these isolates were inferred to be ESBL producers. All isolates were sensitive to imipenem. Susceptibility to gentamicin was 90.5%. The mean continuous hospital stay prior to the detection of bacteremia was 13.7 days overall, but significantly longer in the CRKP group (21.9 d) compared to the CSKP group (4.3 d) (P = 0.003). Children with CRKP were more likely to have received antibiotics in the 2 weeks prior to detection of bacteremia (87.5% of cases) than the CSKP group (20.0% of cases) (P = 0.0008). Sepsis-related mortality was higher in those with CRKP (50.0%) than in the CSKP group (13.3%) (P = 0.02). Patients who did not receive CRKP-directed antibiotics within 48 hours of admission were more likely to have a fatal outcome than those who did (P = 0.009). Logistic regression analysis identified use of third-generation cephalosporins 2 weeks prior to presentation and a hospital stay of 2 weeks or more as independent risk factors for development of CRKP. CONCLUSIONS: More than half of total K. pneumoniae isolated from blood cultures in the unit were ceftazidime-resistant. Children with febrile neutropenia with prolonged hospital stay and recent prior antibiotic exposure are at high risk of developing CRKP bacteremia. Mortality was significantly higher in this group. Early commencement of appropriate antibiotics (e.g., imipenem with or without gentamicin), according to susceptibility study results, may be beneficial in such circumstances.


Subject(s)
Bacteremia/epidemiology , Ceftazidime/pharmacology , Cephalosporins/pharmacology , Klebsiella Infections/epidemiology , Klebsiella pneumoniae/drug effects , Anti-Bacterial Agents/therapeutic use , Bacteremia/drug therapy , Bacteremia/microbiology , Ceftazidime/therapeutic use , Cephalosporins/therapeutic use , Child , Child, Preschool , Drug Resistance, Microbial , Drug Therapy, Combination , Fever/complications , Humans , Infant , Infant, Newborn , Klebsiella Infections/drug therapy , Klebsiella Infections/microbiology , Klebsiella pneumoniae/isolation & purification , Neutropenia/complications , Treatment Outcome
8.
Article in English | MEDLINE | ID: mdl-10695803

ABSTRACT

To study the distribution of presenting features and their prognostic significance in neuroblastoma treated in a single institution in Malaysia. A retrospective study was made of 78 neuroblastoma cases diagnosed and treated in the University Hospital, Kuala Lumpur, Malaysia between June 1982 and February 1997. Diagnosis was established by standard histological criteria. The presenting features were evaluated for their distribution and prognostic influence. Disease-free survival from diagnosis was the outcome variable of interest. The ages ranged from 0.1 to 11 years old (median: 3 years old). The tumor originated from the adrenal glands in 83% and the majority of cases presented in advanced stage (stage III 22%, stage IV 66%). Bone marrow was the commonest site of distant metastasis occurring in 45% of patients. The main presenting signs and symptoms in decreasing order were pallor, fever, abdominal mass, weight loss, and bone/joint pain. Univariate analysis conferred age, initial stage and Hb level as significant prognostic factors. No influence in disease-free survival was found for sex, race, primary site, urinary vanillylmandelic acid level, white cell count and platelet count. Overall 2-year disease-free survival was achieved in 27 (39%) patients. Four patients underwent bone marrow transplant, three of whom achieved 2-year disease-free survival. The results suggest that age, initial stage and hemoglobin level are significant prognostic factors based on univariate analysis. In addition, more Malaysian children presented with adrenal primary site and advanced disease compared to previous reported studies.


Subject(s)
Adrenal Gland Neoplasms/diagnosis , Adrenal Gland Neoplasms/therapy , Neuroblastoma/diagnosis , Neuroblastoma/therapy , Adrenal Gland Neoplasms/complications , Adrenal Gland Neoplasms/mortality , Adrenal Gland Neoplasms/pathology , Age Distribution , Analysis of Variance , Child , Child, Preschool , Combined Modality Therapy , Disease-Free Survival , Female , Fever/etiology , Hemoglobins/analysis , Humans , Infant , Malaysia/epidemiology , Male , Neoplasm Staging , Neuroblastoma/complications , Neuroblastoma/mortality , Neuroblastoma/pathology , Pain/etiology , Pallor/etiology , Prognosis , Retrospective Studies , Treatment Outcome , Weight Loss
11.
Article in English | MEDLINE | ID: mdl-9031421

ABSTRACT

The spectrum of beta-thalassemia mutations in Malays in Singapore and Kelantan (Northeast Malaysia) was studied. Allele specific priming was used to determine the mutations in beta-carriers at -28, Codon 17, IVSI #1, IVSI #5, Codon 41-42 and IVSII #654 along the beta-globin gene. The most common structural hemoglobin variant in Southeast Asia, Hb E, was detected by DNA amplification with restriction enzyme (Mnl1) analysis. Direct genomic sequencing was carried out to detect the beta-mutations uncharacterized by allele-specific priming. The most prevalent beta-mutations in Singaporean Malays were IVSI #5 (45.83%) followed by Hb E (20.83%), codon 15 (12.5%) and IVSI #1 and IVSII #654 at 4.17% each. In contrast, the distribution of the beta-mutations in Kelantan Malays differed, with Hb E as the most common mutation (39.29%) followed by IVSI #5 (17.86%), codon 41-42 (14.29%), codon 19 (10.71%) and codon 17 (3.57%). The beta-mutations in Kelantan Malays follow closely the distribution of beta-mutations in Thais and Malays of Southern Thailand and Malays of West Malaysia. The AAC-->AGC base substitution in codon 19 has been detected only in these populations. The spectrum of beta-mutations in the Singaporean Malays is more similar to those reported in Indonesia with the beta-mutation at codon 15 (TGG-->TAG) present in both populations. The characterization of beta-mutations in Singaporean and Kelantan Malays will facilitate the establishment of effective prenatal diagnosis programs for beta-thalassemia major in this ethnic group.


Subject(s)
DNA Mutational Analysis , Ethnicity/genetics , beta-Thalassemia/genetics , Alleles , Chromosome Mapping , Genetic Carrier Screening , Globins/genetics , Hemoglobin E/genetics , Humans , Malaysia , Polymerase Chain Reaction , Singapore , beta-Thalassemia/ethnology
12.
Asia Oceania J Obstet Gynaecol ; 19(4): 401-5, 1993 Dec.
Article in English | MEDLINE | ID: mdl-8135673

ABSTRACT

Hospital University Sains Malaysia (HUSM) functions as the state referral centre and the only hospital for the state of Kelantan that can offer neonatal intensive care service. The deliveries in HUSM with grand multiparity, late booking and problems of late referrals resembles a hospital serving a semiurban rather than an urban community. A comparison between the year 1989 and 1991 showed marked improvement of perinatal mortality rate from 41.32 to 24.88, which is significantly better than the improvement achieved from 1987 to 1989 (46.0 to 41.32). This was possible due to a marked fall in the early neonatal mortality rate from 10.02 in 1989 to 5.45 in 1991 and fall in the stillbirth rate from 31.61 to 19.53.


PIP: In Malaysia, obstetricians compared 1989 and 1991 perinatal deaths at the Hospital University Sains Malaysia in Kelantan State, the state referral hospital and the only hospital in the state with a neonatal intensive care unit (NICU). There were 46.98% more deliveries in 1991 than in 1989 (7114 vs. 4840). Almost all neonatal deaths took place in the NICU. The perinatal mortality rate fell considerably from 41.32 to 24.88/1000 births, largely due to the declines in the early neonatal mortality rate (10.02-5.45) and the stillbirth rate (31.61-19.53). The rate of very low birth weight (VLBW) infants born increased 11.44% (6.82 vs. 7.5/1000 live births). Their survival rate increased only slightly (54.54-59.37%). Ventilation for VLBW infants suffering from birth asphyxia and meconium aspiration contributed greatly to improvements in survival (31.7% vs. 61.5%). A greater proportion of VLBW infants survived beyond 5 days in 1991 than in 1989 (61.4% vs. 80.2%). In 1991, sepsis was the most frequent cause of death (31.15%). Prematurity also contributed considerably to neonatal mortality. The cause of fetal death was unknown in most cases (51.08%). These findings suggest that better obstetrical management and better ventilatory management of meconium aspiration and birth asphyxia contributed largely to the marked improvement in neonatal survival.


Subject(s)
Fetal Death/epidemiology , Infant Mortality/trends , Female , Humans , Infant, Newborn , Malaysia/epidemiology , Pregnancy
13.
Singapore Med J ; 34(1): 85-6, 1993 Feb.
Article in English | MEDLINE | ID: mdl-8266140

ABSTRACT

We report a neonate with melioidosis. The presentation, progress and treatment are described, followed by a discussion on melioidosis.


Subject(s)
Melioidosis , Fatal Outcome , Humans , Infant, Newborn , Male
14.
Med J Malaysia ; 45(3): 257-9, 1990 Sep.
Article in English | MEDLINE | ID: mdl-2152090

ABSTRACT

A case of primary osteogenic sarcoma of the lumbar spine in child is reported and the difficulties in diagnosis and management are discussed.


Subject(s)
Lumbar Vertebrae , Osteosarcoma , Spinal Neoplasms , Child , Humans , Male , Osteosarcoma/diagnosis , Osteosarcoma/therapy , Spinal Neoplasms/diagnosis , Spinal Neoplasms/therapy
SELECTION OF CITATIONS
SEARCH DETAIL
...